Pharma 4 0 Industry To Spend 4 5 Billion On Digit London, march 23, 2021 prnewswire pharma 4.0 concepts are taking hold in pharmaceutical manufacturing. the industry's unique characteristics are driving investments in digital transformation. The industry’s unique characteristics are driving investments in digital transformation by pharmaceutical manufacturers. global tech market advisory firm abi research forecasts that overall, digital factory revenue will top us$4.5 billion in 2030 with spending by pharmaceutical manufacturers on data analytics forecast to grow by a 27% cagr.
Pharma 4 0 News Ispe International Society For Pharmaceutical March 23, 2021. global tech market advisory firm abi research forecasts that overall, digital factory revenue will top us$4.5 billion in 2030 with spending by pharmaceutical manufacturers on data analytics forecast to grow by a 27% cagr and be worth us$1.2 billion in 2030, as manufacturers look to track, optimize their operations, and boost. Global tech market advisory firm abi research forecasts that overall, digital factory revenue will top us$4.5 billion in 2030 with spending by pharmaceutical manufacturers on data analytics forecast to grow by a 27% cagr and be worth us$1.2 billion in 2030, as manufacturers look to track, optimize their operations, and boost productivity. The pharma industry as a whole is predicted to spend over $4.5 billion on digital transformation , growing by cagr of 27%, and expectations surrounding its impact are high. executives hope that smart, connected factories could deliver savings of , including a drop of 17% in costs related to poor quality product and 14% in delivery reliability. According to the latest abi research report, the pharmaceutical industry is forecast to spend $4.5 billion on digital transformation alone by the year 2030. as the statistics suggest, we’ll be witnessing an era of rapid digitization that could possibly alter the global industrial landscape for good.
Comments are closed.